Molecular portraits and the family tree of cancer - PubMed (original) (raw)
Review
. 2002 Dec:32 Suppl:533-40.
doi: 10.1038/ng1038.
Affiliations
- PMID: 12454650
- DOI: 10.1038/ng1038
Review
Molecular portraits and the family tree of cancer
Christine H Chung et al. Nat Genet. 2002 Dec.
Abstract
The twenty-first century heralds a new era for the biological sciences and medicine. The tools of our time are allowing us to analyze complex genomes more comprehensively than ever before. A principal technology contributing to this explosion of information is the DNA microarray, which enables us to study genome-wide expression patterns in complex biological systems. Although the potential of microarrays is yet to be fully realized, these tools have shown great promise in deciphering complex diseases such as cancer. The early results are painting a detailed portrait of cancer that illustrates the individuality of each tumor and allows familial relationships to be recognized through the identification of cell types sharing common expression patterns.
Similar articles
- Application of gene microarrays in the study of prostate cancer.
Nelson CC, Hoffart D, Gleave ME, Rennie PS. Nelson CC, et al. Methods Mol Med. 2003;81:299-320. doi: 10.1385/1-59259-372-0:299. Methods Mol Med. 2003. PMID: 12725128 No abstract available. - Applications of microarray technology in breast cancer research.
Cooper CS. Cooper CS. Breast Cancer Res. 2001;3(3):158-75. doi: 10.1186/bcr291. Epub 2001 Mar 20. Breast Cancer Res. 2001. PMID: 11305951 Free PMC article. Review. - Cancer Gene Profiling for Response Prediction.
Ghadimi BM, Jo P. Ghadimi BM, et al. Methods Mol Biol. 2016;1381:163-79. doi: 10.1007/978-1-4939-3204-7_9. Methods Mol Biol. 2016. PMID: 26667460 - Clinical application of cDNA microarrays in oncology.
Pusztai L, Ayers M, Stec J, Hortobágyi GN. Pusztai L, et al. Oncologist. 2003;8(3):252-8. doi: 10.1634/theoncologist.8-3-252. Oncologist. 2003. PMID: 12773747 Review. - Functional genomics, gene arrays, and the future of pathology.
Gabrielson E, Berg K, Anbazhagan R. Gabrielson E, et al. Mod Pathol. 2001 Dec;14(12):1294-9. doi: 10.1038/modpathol.3880476. Mod Pathol. 2001. PMID: 11743053 Review.
Cited by
- Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.
Chen B, Yu P, Chan WN, Xie F, Zhang Y, Liang L, Leung KT, Lo KW, Yu J, Tse GMK, Kang W, To KF. Chen B, et al. Signal Transduct Target Ther. 2024 Jan 3;9(1):6. doi: 10.1038/s41392-023-01679-y. Signal Transduct Target Ther. 2024. PMID: 38169461 Free PMC article. Review. - miRNA-Based Technologies in Cancer Therapy.
Pagoni M, Cava C, Sideris DC, Avgeris M, Zoumpourlis V, Michalopoulos I, Drakoulis N. Pagoni M, et al. J Pers Med. 2023 Nov 9;13(11):1586. doi: 10.3390/jpm13111586. J Pers Med. 2023. PMID: 38003902 Free PMC article. Review. - Neuregulin 4 Boosts the Efficacy of Anti-ERBB2 Neutralizing Antibodies.
Miano C, Romaniello D, Mazzeschi M, Morselli A, Da Pra S, Sacchi F, Bongiovanni C, Sgarzi M, Pantano E, Lauriola M, D'Uva G. Miano C, et al. Front Oncol. 2022 May 18;12:831105. doi: 10.3389/fonc.2022.831105. eCollection 2022. Front Oncol. 2022. PMID: 35664762 Free PMC article. - Development of camelid monoclonal nanobody against SLC39A6 zinc transporter protein.
Ghaderi H, Noormohammadi Z, Habibi-Anbouhi M, Kazemi-Lomedasht F, Behdani M. Ghaderi H, et al. Iran J Basic Med Sci. 2021 Dec;24(12):1726-1733. doi: 10.22038/IJBMS.2021.58542.13003. Iran J Basic Med Sci. 2021. PMID: 35432806 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources